Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Distamycin
2. Distamycin A
3. Stallimycin Hydrochloride
4. Stallimycin Monohydrochloride
1. Distamycin A
2. Distamycin
3. 636-47-5
4. Herperetin
5. Stallimycin [inn]
6. Dst-a
7. Nsc82150
8. Nsc-82150
9. Fi 6426
10. Chembl11252
11. 80o63p88is
12. N-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide
13. Ncgc00018292-04
14. Distamycin 3
15. Nsc 150528
16. Estalimicina
17. Stallimicina
18. Stallimycine
19. Stallimycinum
20. Distamicina A
21. Distamycin Hydrochloride
22. 1h-pyrrole-2-carboxamide, N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1h-pyrrol-3-yl)-4-(((4-(formylamino)-1-methyl-1h-pyrrol-2-yl)carbonyl)amino)-1-methyl-
23. 1h-pyrrole-2-carboxamide, N-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1h-pyrrol-3-yl]-4-[[[4-(formylamino)-1-methyl-1h-pyrrol-2-yl]carbonyl]amino]-1-methyl-
24. Nsc150528
25. Stallimicina [dcit]
26. Distamicina A [italian]
27. Stallimycine [inn-french]
28. Stallimycinum [inn-latin]
29. Estalimicina [inn-spanish]
30. Unii-80o63p88is
31. Nsc 82150
32. Brn 0468437
33. Dst-3
34. Distamycin A [mi]
35. Dsstox_cid_25637
36. Dsstox_rid_81018
37. Dsstox_gsid_45637
38. Distamycin; Stallimycin
39. Schembl108585
40. Dtxsid9045637
41. Cid_6602691
42. Zinc3872327
43. Tox21_110857
44. Bdbm50055659
45. Ccg-36393
46. N''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-n-4':n'-4''-ter-(2-pyrrolcarboxamid)
47. Ncgc00018292-01
48. Ncgc00018292-02
49. Ncgc00018292-03
50. Ncgc00018292-05
51. Ncgc00024382-03
52. Cas-636-47-5
53. Nci60_041805
54. Sr-01000000269
55. Sr-01000000269-3
56. Q27269162
57. N,4''-ter[pyrrole-2-carboxamide], N''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-
58. (n,4':n',4''-terpyrrole)-2-carboxamide, N''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-
59. 2n-(3,3-aminoiminopropyl)-4-[4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolylcarboxamido]-1-methyl-1h-2-pyrrolecarboxamide
60. 2n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-3-pyrrolyl]-4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolecarboxamide
61. 2n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-3-pyrrolyl]-4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolecarboxamide(distamycin A)
62. 2n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-3-pyrrolyl]-4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolecarboxamide(distamycin)
63. 39389-47-4
64. 4n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-2-pyrrolyl]-2-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-4-pyrrolecarboxamide
65. 5n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-2,3-dihydro-1h-3-pyrrolyl]-3-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-2,3-dihydro-1h-5-pyrrolecarboxamide
66. N''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-n,4':n',4''-ter(pyrrole-2-carboxamide)
67. N-(3-amino-3-iminopropyl)-4-(4-(4-formamido-1-methyl-1h-pyrrole-2-carboxamido)-1-methyl-1h-pyrrole-2-carboxamido)-1-methyl-1h-pyrrole-2-carboxamide
68. N-[5-({5-[(3-amino-3-iminopropyl)carbamoyl]-1-methyl-1h-pyrrol-3-yl}carbamoyl)-1-methyl-1h-pyrrol-3-yl]-4-(formylamino)-1-methyl-1h-pyrrole-2-carboxamide
69. N-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1h-pyrrol-3-yl]-4-[[[4-(formylamino)-methyl-1h-pyrrol-2-yl]carbonyl]amino]-1h-pyrrole-2-carboxamide
70. N-[5-[[(amino-3-iminopropyl)amino]carbonyl]-1-methyl-1h-pyrrol-3-yl-4-[[(4-(formylamino)-1-methyl-1h-pyrrol-2yl]carbonyl]amino]-1h-pyrrole-2-carboxamide
71. N-[5-[[5-[(3-amino-3-imino-propyl)carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-pyrrol-3-yl]-4-formamido-1-methyl-pyrrole-2-carboxamide
Molecular Weight | 481.5 g/mol |
---|---|
Molecular Formula | C22H27N9O4 |
XLogP3 | -1.8 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 481.21860038 g/mol |
Monoisotopic Mass | 481.21860038 g/mol |
Topological Polar Surface Area | 181 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 825 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
A Distamycin A manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Distamycin A, including repackagers and relabelers. The FDA regulates Distamycin A manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Distamycin A API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Distamycin A manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Distamycin A supplier is an individual or a company that provides Distamycin A active pharmaceutical ingredient (API) or Distamycin A finished formulations upon request. The Distamycin A suppliers may include Distamycin A API manufacturers, exporters, distributors and traders.
click here to find a list of Distamycin A suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Distamycin A DMF (Drug Master File) is a document detailing the whole manufacturing process of Distamycin A active pharmaceutical ingredient (API) in detail. Different forms of Distamycin A DMFs exist exist since differing nations have different regulations, such as Distamycin A USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Distamycin A DMF submitted to regulatory agencies in the US is known as a USDMF. Distamycin A USDMF includes data on Distamycin A's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Distamycin A USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Distamycin A suppliers with USDMF on PharmaCompass.
Distamycin A Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Distamycin A GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Distamycin A GMP manufacturer or Distamycin A GMP API supplier for your needs.
A Distamycin A CoA (Certificate of Analysis) is a formal document that attests to Distamycin A's compliance with Distamycin A specifications and serves as a tool for batch-level quality control.
Distamycin A CoA mostly includes findings from lab analyses of a specific batch. For each Distamycin A CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Distamycin A may be tested according to a variety of international standards, such as European Pharmacopoeia (Distamycin A EP), Distamycin A JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Distamycin A USP).
LOOKING FOR A SUPPLIER?